高级检索
当前位置: 首页 > 详情页

δ-Secretase-cleaved Tau stimulates Aβ production via upregulating STAT1-BACE1 signaling in Alzheimer's disease

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ 自然指数

单位: [1]Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA [2]Wuhan Univ, Renmin Hosp, Dept Neurol, Wuhan 430060, Peoples R China [3]Huazhong Univ Sci & Technol, Tongji Med Coll, Minist Educ China Neurol Disorders, Pathophysiol Dept,Key Lab, Wuhan 430030, Peoples R China [4]Emory Univ, Sch Med, Dept Aneasthesiol, Atlanta, GA 30322 USA [5]Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong 226001, Peoples R China [6]Tongji Univ, Tongji Hosp, Sch Med, Shanghai 200065, Peoples R China
出处:
ISSN:

摘要:
delta-Secretase, an age-dependent asparagine protease, cleaves both amyloid precursor protein (APP) and Tau and is required for amyloid plaque and neurofibrillary tangle pathologies in Alzheimer's disease (AD). However, whether delta-secretase activation is sufficient to trigger AD pathogenesis remains unknown. Here we show that the fragments of delta-secretase-cleavage, APP (586-695) and Tau(1-368), additively drive AD pathogenesis and cognitive dysfunctions. Tau(1-368) strongly augments BACE1 expression and A beta generation in the presence of APP. The Tau(1-368) fragment is more robust than full-length Tau in binding active STAT1, a BACE1 transcription factor, and promotes its nuclear translocation, upregulating BACE1 and A beta production. Notably, A beta-activated SGK1 or JAK2 kinase phosphorylates STAT1 and induces its association with Tau(1-368). Inhibition of these kinases diminishes stimulatory effect of Tau(1-368). Knockout of STAT1 abolishes AD pathologies induced by delta-secretase-generated APP and Tau fragments. Thus, we show that Tau may not only be a downstream effector of A beta in the amyloid hypothesis, but also act as a driving force for A beta, when cleaved by delta-secretase.

语种:
高被引:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 1 区 医学
小类 | 1 区 生化与分子生物学 1 区 神经科学 1 区 精神病学
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 生化与分子生物学 1 区 神经科学 1 区 精神病学
JCR分区:
出版当年[2019]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Q1 NEUROSCIENCES Q1 PSYCHIATRY
最新[2023]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Q1 NEUROSCIENCES Q1 PSYCHIATRY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者单位: [1]Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA [2]Wuhan Univ, Renmin Hosp, Dept Neurol, Wuhan 430060, Peoples R China
通讯作者:
通讯机构: [1]Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA [3]Huazhong Univ Sci & Technol, Tongji Med Coll, Minist Educ China Neurol Disorders, Pathophysiol Dept,Key Lab, Wuhan 430030, Peoples R China [5]Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong 226001, Peoples R China [6]Tongji Univ, Tongji Hosp, Sch Med, Shanghai 200065, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:434 今日访问量:0 总访问量:419 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)